first vaccination – Page 8 – Communicable Diseases Research

Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study

Observational Study

Published on 2022-01-012022-10-04
Journal: The Lancet. Infectious Diseases [Category] 임상,

GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study

Research

Published on 2021-12-292022-10-28
Journal: The BMJ [Category] COVID-19, Fulltext, SARS,

[키워드] 95% confidence interval abdominal pain adjusted hazard ratio Analysis Anxiety Asthma Aurum breathlessness Chest clinical Cognitive impairment cohorts Community contributing to Cox regression database Depression described determine Diagnosis diarrhoea disease Diseases dose England first vaccination Follow-up healthcare hospital individual Infection Influenza Ischaemic heart disease joint Loss of Smell Lung fibrosis median age nausea negative control neuropathic non-steroidal anti-inflammatory drug objective outcome outcome measure Pain pandemic Paracetamol participant Patient patients with influenza Population Practice proportions Rate reduced relative renal repeated Result setting significantly higher symptomatic Symptoms vaccination Venous Thromboembolism
[DOI] 10.1136/bmj-2021-065834 PMC 바로가기 [Article Type] Research

Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination

Article

Published on 2021-12-272022-10-04
Journal: Scientific Reports [Category] SARS, 치료기술,

Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment

Research Report

Published on 2021-12-232022-10-31
Journal: Cancer immunology, immunotherapy : CII [Category] COVID-19,

[키워드] Adverse adverse event adverse events AEs antibody approved Cancer cancer patient Cancer patients clinical cohort study combination treatment coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine dose eight event fatigue first vaccination FIVE follow-up time Frequency Germany grade 3 Immune-checkpoint inhibitors Immunotherapy information inhibitor injection investigated Ipilimumab irAE median Melanoma men Mild moderate pain mRNA-based nivolumab Patient patients patients’ medical records Precaution receiving reported retrieved Safe Seven Side effect Side effects supplementary material the timing therapy treated Treatment vaccination Vaccine was used
[DOI] 10.1007/s00262-021-03133-w PMC 바로가기 [Article Type] Research Report

Retinal Hemorrhage after SARS-CoV-2 Vaccination

Article

Published on 2021-12-052022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patients

혈액투석 환자에서 SARS-CoV-2 중화항체의 장기 궤적과 1차 접종으로 유도된 IgG 항체의 예측가

Nephrology - Original Paper

Published on 2021-12-032022-09-12
Journal: International urology and nephrology [Category] SARS, 진단,

[키워드] 95% CI Accuracy analysed Analysis ANOVA Antibody titer Antibody titer trajectory Antibody titers baseline calculate Chi-squared test comparable COVID-19 declined dialysis Effectiveness Evidence evidence of Evolution Factor first and second dose first dose first vaccination Follow-up General population healthy controls Hemodialysis IgG IgG antibodies IgG antibody IgG titer IgG titers immunization immunosuppressive Immunosuppressive medication immunosuppressive therapy Long-term follow-up low-dose medication Neutralizing Neutralizing activity Neutralizing antibodies neutralizing capacity neutralizing effect non-responder outcome over participant Patient patients per day positive IgG antibodies Post-vaccine potential risk predict predicted Predictive Predictive value Protective Relative risk remained Responder responders Result risk risk factor SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-CoV-2 neutralizing antibody SARS-CoV-2 vaccination second dose second vaccination sensitivity seroconversion rate specificity therapy trajectory vaccination was performed
[DOI] 10.1007/s11255-021-03076-2 PMC 바로가기 [Article Type] Nephrology - Original Paper

Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer A US Nationwide Veterans Affairs Study

암 환자의 SARS-CoV-2 감염과 COVID-19 예방 접종의 연관성 미국 전역 재향 군인 연구

Multicenter Study

Published on 2021-12-022022-09-10
Journal: JAMA Oncology [Category] COVID19(2023년), MERS, SARS, 치료기술,

[키워드] 1:1 95% CI Affair age association Cancer cancer type Care Chemotherapy Cohort cohort study Control controls COVID-19 COVID-19 vaccination death defined determine dose effective Effectiveness eligibility criteria eligible Endocrine Endocrine Therapy Ethnicity exposure finding first vaccination Follow-up for inclusion Health Health care Health care system hematologic Immunosuppressed Importance increased risk individuals Infection infection rate measure median multicenter objective outcomes participant Patient patients Patients with cancer Point positive result Primary outcome receipt receiving Relevance Result risk risk ratio risk reduction rurality SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose serologic testing setting severe COVID-19 solid tumor solid tumors subgroup systemic therapy the vaccine therapy Treatment tumors vaccinated individual vaccinated individuals vaccination Vaccine vaccine dose vaccine response veteran white
[DOI] 10.1001/jamaoncol.2021.5771 PMC 바로가기 [Article Type] Multicenter Study

SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors

CDK4/6 억제제를 투여받는 유방암 환자의 첫 번째 백신 접종 후 SARS-CoV-2 중화 항체

Article

Published on 2021-12-012022-09-12
Journal: Breast (Edinburgh, Scotland) [Category] MERS, SARS, 진단,

The dynamics of quantitative SARS-CoV-2 antispike IgG response to BNT162b2 vaccination

BNT162b2 백신 접종에 대한 정량적 SARS-CoV-2 안티스파이크 IgG 반응의 역학

Article

Published on 2021-12-012022-09-12
Journal: Journal of medical virology [Category] MERS, SARS, 진단,

Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients

고형 장기 이식 환자에서 동종 및 이종 mRNA 및 벡터 기반 COVID-19 백신 요법 후 체액성 면역보다 세포 면역이 우세합니다.

Article

Published on 2021-12-012022-09-11
Journal: American journal of transplantation : official jou [Category] SARS, 진단, 치료기술,

[키워드] Analysis analyzed antibody CD4 CD4 and CD8 T cells CD4 T cells CD8 T cell CD8 T cells Cell Biology cellular immunity clinical research/practice Control correlated COVID-19 vaccine ELISA first vaccination flow cytometry Heterologous heterologous vaccine homologous homologous or heterologous humoral humoral and cellular immunity Humoral immunity identify IgG Immunity immunocompromised individuals immunogenicity IMPROVE Infection infection and infectious agents - viral infectious agent infectious agents Infectious disease mRNA mRNA-vaccine mRNA-vaccines Neutralization assay Neutralizing activity patients plasmablast plasmablasts priming quantified recipient recipients regimen regimens Responder responders SARS-CoV-2-specific antibodies SARS-CoV-2-specific antibody SARS-CoV-2-specific IgG SARS-CoV-2-specific T cell SARS-CoV-2-specific T cells second vaccination significantly higher solid organ solid organ transplant Specific specific antibodies T cell T cell biology T cells vaccination Vaccine while
[DOI] 10.1111/ajt.16818 PMC 바로가기 [Article Type] Article